Skip to main content

Advertisement

SpringerLink
Log in

Prognostic Impact of Additional Extended Surgical Procedures in Advanced-Stage Primary Ovarian Cancer

  • Gynecologic Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Treatment of advanced-stage ovarian carcinoma includes radical cytoreductive surgery, which aims at removing all visible tumor tissue followed by platinum and paclitaxel chemotherapy. Complete tumor resection may require extended surgical procedures. This paper reports on the prognostic impact of extensive surgery and surgical morbidity in patients with advanced-stage ovarian carcinoma.

Methods

Patients with ovarian carcinoma [Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) stage IIIB–IV] undergoing primary surgery in our tertiary gynecologic oncology unit between 1997 and 2007 were eligible for this study. The impact of established prognostic factors and the interaction with extent of surgical procedures on survival were assessed.

Results

A total of 267 patients aged between 29 and 88 years (median 64 years) were eligible for this study. Overall survival time was improved in patients who underwent complete tumor resection [hazard ratio (HR) 3.61 (1.91–6.61), P < 0.001]. No significant survival difference was observed between completely operated patients in whom extended or standard surgical procedures were applied [HR 1.37 (0.70–2.69), P = 0.358], and severe surgical complications were found to be equally distributed between the two patient groups.

Conclusions

Our results may encourage the application of extended surgical procedures in patients who would otherwise be rendered incompletely debulked after primary cytoreduction. We could demonstrate an impact of complete tumor resection on patient prognosis and this was not traded off for extensive additional surgical morbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. du Bois A, Quinn M, Thigpen T, et al. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol. 2005;16(Suppl 8):viii7–viii12.

    Google Scholar 

  2. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248–59.

    Article  PubMed  Google Scholar 

  3. du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO). Cancer. 2009;115:1234–44.

    Article  CAS  PubMed  Google Scholar 

  4. Montz FJ, Schlaerth JB, Berek JS. Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer. Gynecol Oncol. 1989;35:338–40.

    Article  CAS  PubMed  Google Scholar 

  5. Chen LM, Leuchter RS, Lagasse LD, Karlan BY. Splenectomy and surgical cytoreduction for ovarian cancer. Gynecol Oncol. 2000;77:362–8.

    Article  CAS  PubMed  Google Scholar 

  6. Merideth MA, Cliby WA, Keeney GL, Lesnick TG, Nagorney DM, Podratz KC. Hepatic resection for metachronous metastases from ovarian carcinoma. Gynecol Oncol. 2003;89:16–21.

    Article  PubMed  Google Scholar 

  7. Eisenhauer EL, Abu-Rustum NR, Sonoda Y, et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol Oncol. 2006;103:1083–90.

    Article  PubMed  Google Scholar 

  8. Kruskal WH, Wallis WAL. Use of ranks in one-criterion variance analysis. J Am Stat Assoc. 1952;47:583–621.

    Article  Google Scholar 

  9. Armitage PBG. Statistical methods in medical research, 3rd ed. Oxford: Blackwell; 1994.

    Google Scholar 

  10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.

    Article  Google Scholar 

  11. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163–70.

    CAS  PubMed  Google Scholar 

  12. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187–202.

    Google Scholar 

  13. Meigs J. Tumors of the female pelvic organs. New York: Macmillan; 1934.

    Google Scholar 

  14. Hoskins WJ, McGuire WP, Brady MF, Homesley HD, Creasman WT, Berman M, Ball H, Berek JS. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol. 1994;170:974–9; discussion 979–80.

    CAS  PubMed  Google Scholar 

  15. Eisenkop SM, Friedman RL, Wang HJ. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol. 1998;69:103–8.

    Article  CAS  PubMed  Google Scholar 

  16. Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol. 1999;72:278–87.

    Article  CAS  PubMed  Google Scholar 

  17. Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr. 1975;42:101–4.

    CAS  PubMed  Google Scholar 

  18. Piver MS, Baker T. The potential for optimal (less than or equal to 2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: a prospective study. Gynecol Oncol. 1986;24:1–8.

    Article  CAS  PubMed  Google Scholar 

  19. Aletti GD, Dowdy SC, Gostout BS, et al. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol. 2006;107:77–85.

    PubMed  Google Scholar 

  20. Chi DS, Eisenhauer EL, Lang J, et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol. 2006;103:559–64.

    Article  CAS  PubMed  Google Scholar 

  21. Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Aghajanian C, Barakat RR, Chi DS. The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer. Gynecol Oncol. 2008;108:276–81.

    Article  CAS  PubMed  Google Scholar 

  22. Eisenkop SM, Spirtos NM. Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with “biological aggressiveness” and survival? Gynecol Oncol. 2001;82:435–41.

    Article  CAS  PubMed  Google Scholar 

  23. Covens AL. A critique of surgical cytoreduction in advanced ovarian cancer. Gynecol Oncol. 2000;78:269–74.

    Article  CAS  PubMed  Google Scholar 

  24. Markman M. Concept of optimal surgical cytoreduction in advanced ovarian cancer: a brief critique and a call for action. J Clin Oncol. 2007;25:4168–70.

    Article  PubMed  Google Scholar 

  25. Hacker NF. Controversial aspects of cytoreductive surgery in epithelial ovarian cancer. Baillieres Clin Obstet Gynaecol. 1989;3:49–57.

    Article  CAS  PubMed  Google Scholar 

  26. Le T, Krepart GV, Lotocki RJ, Heywood MS. Does debulking surgery improve survival in biologically aggressive ovarian carcinoma? Gynecol Oncol. 1997;67:208–14.

    Article  CAS  PubMed  Google Scholar 

  27. Naik R, Nordin A, Cross PA, Hemming D, de Barros Lopes A, Monaghan JM. Complete cytoreduction: is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease? Gynecol Oncol. 2000;78:176–80.

    Article  CAS  PubMed  Google Scholar 

  28. Spirtos NM, Gross GM, Freddo JL, Ballon SC. Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy. Gynecol Oncol. 1995;56:345–52.

    Article  CAS  PubMed  Google Scholar 

  29. Aletti GD, Podratz KC, Moriarty JP, Cliby WA, Long KH. Aggressive and complex surgery for advanced ovarian cancer: an economic analysis. Gynecol Oncol. 2009;112:16–21.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Klinik, Wiesbaden, Germany

    S. Kommoss MD, P. Harter MD, F. Heitz MD, J. P. Grabowski MD, N. Ewald-Riegler MD, M. Haberstroh MD, T. Neunhoeffer MD, J. Barinoff MD, R. Gomez MD, A. Traut & A. du Bois MD

  2. Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany

    J. Rochon

Authors
  1. S. Kommoss MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Rochon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Harter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Heitz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. P. Grabowski MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N. Ewald-Riegler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Haberstroh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T. Neunhoeffer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. Barinoff MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. R. Gomez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. A. Traut
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A. du Bois MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Kommoss MD.

Electronic supplementary material

Below is the link to the electronic supplementary material.

(PDF 402 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kommoss, S., Rochon, J., Harter, P. et al. Prognostic Impact of Additional Extended Surgical Procedures in Advanced-Stage Primary Ovarian Cancer. Ann Surg Oncol 17, 279–286 (2010). https://doi.org/10.1245/s10434-009-0787-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-009-0787-8

Keywords

Search

Navigation